Join
Live feed
·
PRReleasevia Quantisnow
Generate Biomedicines Inc. logo

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

ByQuantisnow·Wall Street's wire, on your screen.
GENB· Generate Biomedicines Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GENB (Generate Biomedicines Inc.) and more on Quantisnow.